“…No statistical differences in hepatic FGF19 ( P = .86), hepatic FGFR4 ( P = .53), a receptor for FGF19, hepatic CyP7A1 ( P = .61), or hepatic FXR ( P = .75) were noted between the 2 groups (Figure ). In addition, no statistical differences in known CDCA‐modulated hepatic receptors, small heterodimer partner (SHP), constitutive androstane receptor (CAR), organic solute steroid transporter (OSTα), multidrug‐associated protein (MRP), or peroxisome proliferator‐activated receptor (PPAR) were noted between the groups.…”